ONCE DAILY TREATMENT OF HEPATITIS C WITH RIBAVIRIN AND TARIBAVIRIN

• 1. 用替拉瑞韦(VX-950)治疗对聚乙二醇化干扰素α-2A/2B和利巴韦林治疗无应答患者的丙型肝炎病毒感染 [P] . 中国专利： CN102083433A . 2011-06-01
• 2. 使用胸腺素、干扰素和利巴韦林治疗丙型肝炎 [P] . 中国专利： CN1446096A . 2003-10-01
• 3. ONCE DAILY TREATMENT OF HEPATITIS C WITH RIBAVIRIN AND TARIBAVIRIN [P] . 欧洲知识产权局专利： EP2809334A4 . 2015-06-24

  机译： 利巴韦林和塔利巴韦林一次治疗丙型肝炎

• 4. ONCE DAILY TREATMENT OF HEPATITIS C WITH RIBAVIRIN AND TARIBAVIRIN [P] . 美国专利： US2014363396A1 . 2014-12-11

  机译： 利巴韦林和塔利巴韦林一次治疗丙型肝炎

• 5. ONCE DAILY TREATMENT OF HEPATITIS C WITH RIBAVIRIN AND TARIBAVIRIN [P] . CA2863645A1 . 2013-08-08

  机译： 利巴韦林和塔利巴韦林一次治疗丙型肝炎

• 1. Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C. [J] . Poordad F, Lawitz E, Shiffman ML, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2010,第4期
• 2. Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial. [J] . Van Vlierberghe H, Leroux Roels G, Adler M, Journal of viral hepatitis. . 2003,第6期
• 3. Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-na?ve hepatitis C genotype 1-infected patients in Japan: The DRAGON study [J] . HayashiN., SetoC., KatoM., Journal of gastroenterology . 2014,第1期
• 4. HLA-C gene in Hepatitis C Virus infected Patients in Egypt, to estimate the relation between HLA-C gene and Interferon/Ribavirin as treatment for hepatitis C virus [C] . SHADEN MUAWIA HANAFY, AMAL AHMED ABBAS, SAFY KABEEL ALY MANSOUR International Conference on Cellular and Molecular Biology, Biophysics and Bioengineering . 2015
• 5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011
• 6. Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin—A Multicenter Study [O] . Subrat K Acharya, V Sreenivas, Siddharth Datta Gupta, 2012
• 7. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta [O] . Y Asahina 2001

• 1. A randomized trial of a 4- vs 12-week daily interferon dose regimen combined with ribavirin in treatment of patients with chronic hepatitis C [J] . Shiv K. Sarin ,Ankur Goyal ,Sudheer Kumar . 国际肝胆胰疾病杂志：英文版 . 2004,第1期
• 2. Immunogenicity of recombinant hepatitis B vaccine in treatment-nave and treatment-experienced chronic hepatitis C patients: The effect of pegylated interferon plus ribavirin treatment [J] . Ioannis S Elefsiniotis ,Elena Vezali ,Konstantinos Kamposioras . 世界胃肠病学杂志：英文版 . 2006,第27期
• 3. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment [J] . Takayuki Kogure ,YoshiyukiUeno ,Koji Fukushima . 世界胃肠病学杂志：英文版 . 2007,第32期
• 4. Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection [J] . En Xian Sarah Low ,Edhel Tripon ,Kieron Lim . 世界肝病学杂志：英文版（电子版） . 2019,第6期
• 5. Treatment of Hepatitis C with Pegylated Interferon Alpha-2a and Ribavirin:Experience from Benin [J] . Aboudou Raimi Kpossou ,Jean Séhonou ,Gbénagnon Micael Geraud Adjigbe . 肠胃病学期刊（英文） . 2018,第8期
• 6. 聚乙二醇干扰素联合利巴韦林与α干扰素联合利巴韦林治疗慢性丙型肝炎疗效观察 [C] . . 第十七次全国中西医结合肝病学术会议 . 2008
• 7. 索非布韦联合雷迪帕韦及其加用利巴韦林治疗1型丙型肝炎的荟萃分析 [A] . 赵旸 . 2018